Resumption of trastuzumab in patients with disease recurrence after (Neo-) adjuvant anti-HER2-therapy in patients with HER2-positive breast cancer

Lars Christian Hanker*, Frank Förster, Jan Schröder, Andrea Grafe, Thomas Hitschold, Tobias Hesse, Claus Richard Lattrich, Achim Rody

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Resumption of trastuzumab in patients with disease recurrence after (Neo-) adjuvant anti-HER2-therapy in patients with HER2-positive breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry